PolyProx Therapeutics Ltd

PolyProx Therapeutics Ltd is located in Cambridge, United Kingdom on Jonas Webb Building (B910), Babraham Research Campus. PolyProx Therapeutics Ltd is rated 3 out of 5 in the category company in United Kingdom. PolyProx Therapeutics is a spin-out from Cambridge University, Department of Pharmacology based on exciting discoveries in the PROTACs/proteasome field. The company will discover and develop a new class of drugs for the treatment of cancer, using novel engineered proteins that are able to selectively target tumour cells and trigger natural degradation machinery within the cell. This approach promises to address cancer targets that have proved intractable using current technologies, important in major diseases such as lung, colorectal and pancreatic cancers.